Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Oct 7;11(10):1723-1725.
doi: 10.2215/CJN.08910816. Epub 2016 Sep 27.

Patiromer-an Oral Calcium-Loaded Potassium Binder: Kalirrhea with Calciuresis

Michael Emmett  1 , Ankit Mehta
Affiliations
Editorial

Patiromer-an Oral Calcium-Loaded Potassium Binder: Kalirrhea with Calciuresis

Michael Emmett et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: Calcium; Dietary; Polymers; Potassium; calcium; chronic kidney disease; electrolytes; patiromer; phosphate uptake; potassium channels.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Patiromer administration and resultant changes in fecal and urine K, phosphate, and calcium. *Although the serum K did not fall in this study of normal individuals, patiromer has been shown to lower serum K in hyperkalemic patients with chronic kidney disease. Box colors: brown, GI tract; purple, fecal excretion; red, GI absorption changes; gray, hormonal effects; yellow, urinary excretion. Ca, calcium; CaPO4, calcium phosphate; K, potassium; Mg, magnesium; PTH, parathyroid hormone; PO4, phosphate.
See this image and copyright information in PMC

Comment on

  • Effect of Patiromer on Urinary Ion Excretion in Healthy Adults.
    Bushinsky DA, Spiegel DM, Gross C, Benton WW, Fogli J, Hill Gallant KM, Du Mond C, Block GA, Weir MR, Pitt B. Bushinsky DA, et al. Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1769-1776. doi: 10.2215/CJN.01170216. Epub 2016 Sep 27. Clin J Am Soc Nephrol. 2016. PMID: 27679518 Free PMC article. Clinical Trial.

References

    1. Gruy-Kapral C, Emmett M, Santa Ana CA, Porter JL, Fordtran JS, Fine KD: Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 9: 1924–1930, 1998 - PubMed
    1. Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM: Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. Am J Med 126: 264.e9–264.e24, 2013 - PubMed
    1. Bushinsky DA, Spiegel DM, Gross C, Benton WW, Fogli J, Hill Gallant KM, Du Mond C, Block GA, Weir MR, Pitt B: Effect of Patiromer on Urinary Ion Excretion in Healthy Adults. Clin J Am Soc Nephrol 11: 1769–1776, 2016 - PMC - PubMed
    1. Patel L, Bernard LM, Elder GJ: Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Clin J Am Soc Nephrol 11: 232–244, 2016 - PMC - PubMed
    1. Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT: Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382: 1268–1277, 2013 - PubMed

LinkOut - more resources